Pfizer, GlaxoSmithKline JV VIIV Healthcare Received FDA Approval Type 3 – New Dosage Form for TRIUMEQ PD
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215413
Surface Oncology Achieves $30M Milestone With First Patient Dosed In GlaxoSmithKline Phase 1 Study
Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced the first patient has been dosed by
CureVac – GSK Start Dosing In Next-Gen COVID-19 Vaccine Candidate Trial
CureVac N.V. (NASDAQ:CVAC) dosed the first participant in a Phase 1 study of COVID-19 second-generation mRNA vaccine candidate, CV2CoV, developed with GlaxoSmithKline…
EMA Starts Review Of Sanofi-GlaxoSmithKline’s COVID-19 Vaccine
The European Medicines Agency has started reviewing Sanofi SA (NASDAQ:SNY) and its partner GlaxoSmithKline Plc’s (NYSE:GSK) application seeking conditional authorization for their…
Justice Department Probes Network Accused Of Selling Counterfeit HIV Drugs; Investigation Partially Echoes Allegations Made By Gilead In Civil Lawsuit
-Wall Street Journal
-Wall Street Journal
Drug makers, Scientists Working For Long COVID Treatments: Reuters
Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,